Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Carlos Slim Health Institute launches major research project in genomic medicine

Mexican business leader Carlos Slim Hel- today announced the launch of a major research project in genomic medicine that will help accelerate progress in public health in Mexico and around the world.

20 Jan 2010

Fast Forward, JDRF announce collaborative partnership with Axxam SpA

Fast Forward, LLC, the commercial drug development arm of the National Multiple Sclerosis Society, and the Juvenile Diabetes Research Foundation (JDRF), the leader in research leading to a cure for type 1 diabetes in the world today announced a collaborative partnership with Axxam SpA -- a leading company in conducting early-stage discovery research programs for the life science industry -- to develop new treatments for two autoimmune diseases, multiple sclerosis (MS) and type 1 diabetes (T1D).

20 Jan 2010

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) and BD (Becton, Dickinson and Company) announced today an innovative program aimed at improving the treatment of type 1 diabetes by developing novel insulin delivery products to enhance the use of insulin pumps.

From BD (Becton, Dickinson and Company) 20 Jan 2010

Patient enrollment for Phase 2B clinical study of Oramed Pharmaceuticals' ORMD-0801 completed

Oramed Pharmaceuticals Inc. announced today the completion of patient enrollment in the Phase 2B clinical study of its oral insulin capsule, ORMD-0801.

20 Jan 2010

California limits HMO wait times

The regulations by the California Department of Managed Health Care, in the works for much of the last decade, will require that patients be treated by HMO doctors within 10 business days of requesting an appointment, and by specialists within 15.

19 Jan 2010

Incidence of diabetes more prevalent among First Nations women

A diabetes epidemic is affecting First Nations people, especially women in their prime reproductive years, according to a new study in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/embargo/cmaj090846.pdf.

19 Jan 2010

Smoking diabetics more likely to have a heart attack

The Canadian Diabetes Association encourages all Canadians living with diabetes who smoke to take action to quit smoking in the next seven days, during National Non-Smoking Week.

19 Jan 2010

Allergan to jointly promote its adjustable gastric band for bariatric surgery with Covidien

Covidien, a leading global provider of healthcare products, today announced the extension of its agreement with Allergan, Inc. to jointly promote Allergan’s LAP-BAND® System, the top-selling adjustable gastric band for bariatric surgery, in the United States.

18 Jan 2010

Nutrisystem recognized as best among popular weight loss programs

With millions of Americans making it their New Year’s resolution to lose weight and lead a healthier lifestyle, and with the cost of some diet programs rising as high as $10,000 per year, Nutrisystem has been credited by two of the nation’s most respected media outlets for helping consumers shed pounds without lightening their wallets.

18 Jan 2010

MAGIC investigators identify new genetic variants that influence insulin and glucose regulation

An international research consortium has found 13 new genetic variants that influence blood glucose regulation, insulin resistance, and the function of insulin-secreting beta cells in populations of European descent. Five of the newly discovered variants increase the risk of developing type 2 diabetes, the most common form of diabetes.

18 Jan 2010

ASA urges patients to make lifestyle changes before opting for complicated surgeries

At a time of year when people make plans to drop a few pounds, perhaps even consider bariatric surgery, the American Society of Anesthesiologists (ASA) wants to ensure the public has the facts regarding one's weight and the impact it may have on his or her anesthesia experience.

18 Jan 2010

Researchers identify new gene variants associated With glucose, insulin levels

A major international study with leadership from Massachusetts General Hospital (MGH) researchers has identified 10 new gene variants associated with blood sugar or insulin levels. Two of these novel variants and three that earlier studies associated with glucose levels were also found to increase the risk of type 2 diabetes. Along with a related study from members of the same research consortium, associating additional genetic variants with the metabolic response to a sugary meal, the report will appear in Nature Genetics and has been released online.

18 Jan 2010

Fourth edition of IDF Diabetes Atlas reports high incidence of diabetes in developing countries

...

18 Jan 2010

Evidence suggests insulin pumps may help in maintaining blood glucose levels in type 1 diabetic patients

A new evidence review suggests that using a pump to deliver insulin continuously — instead of taking three or more daily injections — might result in better control of blood sugar for people with type 1 diabetes.

18 Jan 2010

Researchers uncover novel genetic markers for diabetes-related traits

In two major studies published in Nature Genetics today, researchers use biological understanding to dissect the genetics of diabetes. An international team comprising researchers from more than 100 institutions analysed vast suites of genetic data from more than 100,000 people of European descent to uncover the associations.

18 Jan 2010

OSA adversely affects glucose control in patients with type 2 diabetes

Obstructive Sleep Apnea (OSA) adversely affects glucose control in patients with type 2 diabetes, according to a study conducted by researchers at the University of Chicago.

18 Jan 2010

JDRF and Animas partner to develop an automated system for better control of type 1 diabetes

The Juvenile Diabetes Research Foundation today announced an innovative partnership with Animas Corporation to develop an automated system to help people with type 1 diabetes better control their disease -- the first step on the path to what would be among the most revolutionary advancements in treating type 1 diabetes: the development of an artificial pancreas, a fully automated system to dispense insulin to patients based on real-time changes in blood sugar levels.

18 Jan 2010

New analysis finds cost of diabetes and pre-diabetes reached $218 billion in 2007

A new analysis found that the cost of diabetes and pre-diabetes reached $218 billion in 2007, with the exploding number of cases of type 2 diabetes responsible for the majority of the costs. The National Changing Diabetes® Program (NCDP), a program of Novo Nordisk, commissioned the analysis, published online as a Web First article today in Health Affairs and performed by researchers at The Lewin Group.

13 Jan 2010

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Emisphere Technologies, Inc. today announced that Novo Nordisk has initiated its first Phase I clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a $2 million payment to Emisphere, whose proprietary Eligen® Technology is used in the formulation of NN9924.

13 Jan 2010

Patient enrollment in Spherix's global Phase 3 clinical trial NEET completed

Spherix Inc., an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced the completion of patient enrollment in its global Phase 3 clinical trial NEET (70971-004), which is evaluating the safety and efficacy of D-tagatose as an oral treatment for Type 2 diabetes mellitus.

12 Jan 2010

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Carlos Slim Health Institute launches major research project in genomic medicine

Fast Forward, JDRF announce collaborative partnership with Axxam SpA

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

Patient enrollment for Phase 2B clinical study of Oramed Pharmaceuticals' ORMD-0801 completed

California limits HMO wait times

Incidence of diabetes more prevalent among First Nations women

Smoking diabetics more likely to have a heart attack

Allergan to jointly promote its adjustable gastric band for bariatric surgery with Covidien

Nutrisystem recognized as best among popular weight loss programs

MAGIC investigators identify new genetic variants that influence insulin and glucose regulation

ASA urges patients to make lifestyle changes before opting for complicated surgeries

Researchers identify new gene variants associated With glucose, insulin levels

Fourth edition of IDF Diabetes Atlas reports high incidence of diabetes in developing countries

Evidence suggests insulin pumps may help in maintaining blood glucose levels in type 1 diabetic patients

Researchers uncover novel genetic markers for diabetes-related traits

OSA adversely affects glucose control in patients with type 2 diabetes

JDRF and Animas partner to develop an automated system for better control of type 1 diabetes

New analysis finds cost of diabetes and pre-diabetes reached $218 billion in 2007

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Patient enrollment in Spherix's global Phase 3 clinical trial NEET completed

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in